RELAY THERAPEUTICS INC. - COMMON STOCK

Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608

05 يونيو 2024 13:05:03 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Upcoming Investor Conferences

21 مايو 2024 13:05:35 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Host New Program and Platform Event on June 6, 2024

13 مايو 2024 05:30:00 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights

02 مايو 2024 13:05:45 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024

25 أبريل 2024 13:05:31 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Upcoming Investor Conferences

11 أبريل 2024 13:05:14 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Three Upcoming Investor Conferences

26 فبراير 2024 13:05:17 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

22 فبراير 2024 13:05:19 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024

15 فبراير 2024 13:05:27 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 فبراير 2024 13:05:05 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces $30 Million Private Placement Financing

08 يناير 2024 04:00:32 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

02 يناير 2024 13:05:12 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference

07 نوفمبر 2023 13:05:18 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights

02 نوفمبر 2023 13:05:42 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023

26 أكتوبر 2023 13:05:51 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors

12 أكتوبر 2023 13:05:00 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

18 سبتمبر 2023 13:05:42 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights

08 أغسطس 2023 13:02:09 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Announce Second Quarter 2023 Financial Results and Corporate Highlights on August 8, 2023

01 أغسطس 2023 13:05:24 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008

25 مايو 2023 14:01:31 بحسب Nasdaq GlobeNewswire